Fundz

Molecular Targeting Technologies, Inc. Appoints Dr. Danielle Meyrick as Chief Medical Officer

PRIVATEJul 22, 2025

Position

Chief Medical Officer

Company

Molecular Targeting Technologies

Danielle Meyrick
West ChesterBiotechnologyHealth Care

Description

Molecular Targeting Technologies, Inc. (MTTI) has appointed Dr. Danielle Meyrick as Chief Medical Officer

Quick answer

Molecular Targeting Technologies, Inc. Appoints Dr. Danielle Meyrick as Chief Medical Officer (July 22, 2025). Molecular Targeting Technologies is based in West Chester, Pennsylvania, United States.

Who is the new Chief Medical Officer at Molecular Targeting Technologies?
Molecular Targeting Technologies named Danielle Meyrick Chief Medical Officer, announced July 22, 2025.
What did Molecular Targeting Technologies announce on July 22, 2025?
Molecular Targeting Technologies, Inc. (MTTI) has appointed Dr. Danielle Meyrick as Chief Medical Officer
What does Molecular Targeting Technologies do?
Molecular Targeting Technologies, Inc. (MTTI) is a private, clinical-stage biotech company developing targeted radiopharmaceuticals (TRP) for rare cancers.
Where is Molecular Targeting Technologies based?
Molecular Targeting Technologies is based in West Chester, Pennsylvania, United States.
Which similar companies made leadership changes around the same time?
Llusern Scientific (July 22, 2025), MED-X (July 22, 2025), CASI Pharmaceuticals (July 21, 2025) and Minaris Advanced Therapies (July 21, 2025) also announced leadership changes within 45 days of Molecular Targeting Technologies.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Molecular Targeting Technologies, and when

A new leader at Molecular Targeting Technologies brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Molecular Targeting Technologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Molecular Targeting Technologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Molecular Targeting Technologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Molecular Targeting Technologies

Location

West Chester, Pennsylvania, United States

About

Molecular Targeting Technologies, Inc. (MTTI) is a private, clinical-stage biotech company developing targeted radiopharmaceuticals (TRP) for rare cancers. MTTI is committed to building value by translating innovative TRP to improve human health.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Molecular Targeting Technologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Brian
Senior decision-maker at this company
••••••••@••••••••

See Brian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Molecular Targeting Technologies's next move

Learn about Strategic plan

Molecular Targeting Technologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.